T lymphocytes in systemic lupus erythematosus: An update

Current Opinion in Rheumatology

Volumn 16, Issue 5, 2004, Pages 548-552

  Kyttaris, Vasileios C ^b   Tsokos, George C ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b NONE

Author keywords

chain; Apoptosis; Interleukin 2; Systemic lupus erythematosus; T cells; T cell receptor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

CALCIUM TRANSPORT; CELL FUNCTION; CYTOKINE PRODUCTION; HUMAN; IMMUNOPATHOGENESIS; INTRACELLULAR TRANSPORT; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

APOPTOSIS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RECEPTORS, ANTIGEN, T-CELL; RHEUMATOLOGY; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 4344597820     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bor.0000132646.55056.e0     Document Type: Review

References (36)

1. Tsokos GC, Boumpas DT: Systemic lupus erythematosus. In: Molecular Pathology of Autoimmunity. Edited by Theofilopoulos A, Bona C. Gordon and Breach, Harwood Academic Publishers; 2001:255-281.
2. Klinman DM, Mushinski JF, Honda M, et al.: Oncogene expression in autoimmune and normal peripheral blood mononuclear cells. J Exp Med 1986, 163:1292.
3. Inghirami G, Simon J, Balow JE, et al.: Activated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulin. Clin Exp Rheumatol 1988, 6:269-276.
4. Tsokos GC, Liossis SN: Immune cell signaling defects in lupus: activation, anergy and death. Immunol Today 1999, 20:119.
5. Iliopoulos AG, Tsokos GC: Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin Arthritis Rheum 1996, 25:318.
6. Kang I, Quan T, Nolasco H, et al.: Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol 2004, 172:1287-1294.
7. De Silva-Udawatta M, Kumar SR, Greidinger EL, et al.: Cloned human TCR from patients with autoimmune disease can respond to two structurally distinct autoantigens. J Immunol 2004, 172:3940-3947. This article explores TCR plasticity in SLE. TCR from lupus T cells specific for one autoantigen is shown also to cross-react with another distinct autoantigen. This concept can help explain the epitope spreading seen in many autoimmune conditions.
8. Liossis S-NC, Ding XZ, Dennis GJ, et al.: Altered pattern of TcR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus: deficient expression of the T cell receptor zeta chain. J Clin Invest 1998, 101:1448-1457.
9. Juang Y-T, Tenbrock K, Nambiar MP, et al.: Defective production of functional 98-kDa form of elf-1 is responsible for the decreased expression of TCR-æ chain in patients with systemic lupus erythematosus. J Immunol 2002, 169:6048-6055.
10. Tsuzaka K, Fukuhara I, Setoyama Y, et al.: TCR zeta mRNA with an alternatively spliced 3′-untranslated region detected in systemic lupus erythematosus patients leads to the down-regulation of TCR zeta and TCR/CD3 complex. J Immunol 2003, 171:2496-2503.
11. Nambiar MP, Enyedy EJ, Fisher CU, et al.: Abnormal expression of various molecular forms and distribution of T cell receptor zeta chain in patients with systemic lupus erythematosus. Arthritis Rheum 2002, 46:163-174.
12. Jury EC, Kabouridis PS, Abba A, et al.: Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum 2003, 48:1343-1354.
13. Enyedy EJ, Nambiar MP, Liossis SN, et al.: Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus. Arthritis Rheum 2001, 44:1114-1121.
14. Krishnan S, Warke VG, Nambiar MP, et al.: The FcR gamma subunit and Syk kinase replace the CD3 zeta-chain and ZAP-70 kinase in the TCR signaling complex of human effector CD4 T cells. J Immunol 2003, 170:4189. The FcRγ-chain substitutes the ζ-chain in TCR effector T cells, resulting in signaling through the TCR that can be 100-fold increased. This observation may help explain the heightened calcium response in the lupus T cell that is TCR ζ-chain-deficient.
15. Krishnan S, Nambiar MP, Warke VG, et al.: Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus. J Immunol 2004, in press.
16. Nambiar MP, Fisher CU, Warke VG, et al.: Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus. Arthritis Rheum 2003, 48:1948-1955.
17. Tsai HF, Lai JJ, Chou AH, et al.: Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus. Arthritis Rheum 2004, 50:629-639.
18. Liu MF, Wang CR, Fung LL, et al.: Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 2004, 59:198-202.
19. Liu Z, Xu X, Hsu HC, et al.: CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis. J Clin Invest 2003, 112:1332-1341.
20. Amoura Z, Combadiere C, Faure S, et al.: Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares. Arthritis Rheum 2003, 48:3487-3496.
21. Segerer S, Banas B, Wornle M, et al.: CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis. Am J Pathol 2004, 164:635-649.
22. Flier J, Boorsma DM, van Beek PJ, et al.: Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol 2001, 194:398-405.
23. Cedeno S, Cifarelli DF, Blasini AM, et al.: Defective activity of ERK-1 and ERK-2 mitogen-activated protein kinases in peripheral blood T lymphocytes from patients with systemic lupus erythematosus: potential role of altered coupling of Ras guanine nucleotide exchange factor hSos to adapter protein Grb2 in lupus T cells. Clin Immunology 2003, 106:41-49.
24. Kammer GM: Deficient protein kinase a in systemic lupus erythematosus: a disorder of T lymphocyte signal transduction. Ann N Y Acad Sci 2002, 968:96-105.
25. Elliott MR, Tolnay M, Tsokos GC, et al.: Protein kinase A regulatory subunit type II beta directly interacts with and suppresses CREB transcriptional activity in activated T cells. J Immunol 2003, 171:3636-3644.
26. Elliott MR, Shanks RA, Brooks JW, et al.: Down-regulation of IL-2 production in T Lymphocytes by phosphorylated protein kinase A-RIIβ. J Immunol 2004, in press.
27. Herndon TM, Juang Y-T, Solomou E, et al.: Electroporation-mediated gene transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity. Clin Immunol 2002, 103:145-153.
28. Solomou EE, Juang Y-T, Gourley MF, et al.: Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus. J Immunol 2001, 166:4216-4222.
29. Tenbrock K, Juang Y-T, Gourley MF, et al.: Antisense cyclic adenosine 5′-monophosphate response element modulator up-regulates IL-2 in T cells from patients with systemic lupus erythematosus. J Immunol 2002, 169:4147-4152.
30. Kyttaris VC, Juang Y-T, Tenbrock K, et al.: cAMP response element modulator is responsible for the decreased expression of c-fos and AP-1 binding in T cells from patients with systemic lupus erythematosus. J Immunol 2004, in press.
31. Xu L, Zhang L, Yi Y, et al.: Human lupus T cells resist inactivation and escape death by upregulating COX-2. Nat Med 2004, 10:411-415. A novel mechanism through which lupus T cells escape AICD and anergy is explored in this article. T cells from patients with SLE upregulate COX-2 on activation. Blocking that molecule with celecoxib induced apoptosis that was associated with increased Fas signaling.
32. Xiao S, Sung SS, Fu SM, et al.: Combining Fas mutation with interleukin-2 deficiency prevents colitis and lupus: implicating interleukin-2 for autoreactive T cell expansion and Fas ligand for colon epithelial cell death. J Biol Chem 2003, 278:52730-52738.
33. Kong PL, Morel L, Croker BP, et al.: The centromeric region of chromosome 7 from MRL mice (Lmb3) is an epistatic modifier of Fas for autoimmune disease expression. J Immunol 2004, 172:2785-2794.
34. Waters ST, McDuffie M, Bagavant H, et al.: Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J Exp Med 2004, 199:255-264.
35. Tenbrock K, Juang Y-T, Tolnay M, et al.: The cyclic adenosine 5′-monophosphate response element modulator suppresses IL-2 production in stimulated T cells by a chromatin-dependent mechanism. J Immunol 2003, 170:2971-2976.
36. Mishra N, Reilly CM, Brown DR, et al.: Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J Clin Invest 2003, 111:539-552.